BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22650261)

  • 1. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of inhibitors of Bcl-2 family protein-protein interaction by combining the BRET screening platform with virtual screening.
    Park IS; Seo HR; Kim K; Lee H; Shum D; Choi I; Kim J
    Biochem Biophys Res Commun; 2020 Jun; 527(3):709-715. PubMed ID: 32423828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of high-confidence protein-protein interactome in yeast.
    Karagoz K; Arga KY
    Comput Biol Chem; 2013 Aug; 45():1-8. PubMed ID: 23608186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving small molecule virtual screening strategies for the next generation of therapeutics.
    Wingert BM; Camacho CJ
    Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the Right Choice: Critical Parameters of the Y2H Systems.
    Mehla J; Caufield JH; Uetz P
    Methods Mol Biol; 2018; 1794():17-28. PubMed ID: 29855948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using fragment-based technologies to target protein-protein interactions.
    Bower JF; Pannifer A
    Curr Pharm Des; 2012; 18(30):4685-96. PubMed ID: 22650253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Databases of protein-protein interactions and their use in drug discovery.
    Fuentes G; Oyarzabal J; Rojas AM
    Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
    Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
    BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modelling as a virtual screening tool for the discovery of small molecule protein-protein interaction inhibitors.
    Voet A; Zhang KY
    Curr Pharm Des; 2012; 18(30):4586-98. PubMed ID: 22650262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53.
    Wong JH; Alfatah M; Sin MF; Sim HM; Verma CS; Lane DP; Arumugam P
    BMC Biol; 2017 Nov; 15(1):108. PubMed ID: 29121928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interaction networks as miners of biological discovery.
    Wang S; Wu R; Lu J; Jiang Y; Huang T; Cai YD
    Proteomics; 2022 Aug; 22(15-16):e2100190. PubMed ID: 35567424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-quality binary protein interaction map of the yeast interactome network.
    Yu H; Braun P; Yildirim MA; Lemmens I; Venkatesan K; Sahalie J; Hirozane-Kishikawa T; Gebreab F; Li N; Simonis N; Hao T; Rual JF; Dricot A; Vazquez A; Murray RR; Simon C; Tardivo L; Tam S; Svrzikapa N; Fan C; de Smet AS; Motyl A; Hudson ME; Park J; Xin X; Cusick ME; Moore T; Boone C; Snyder M; Roth FP; Barabási AL; Tavernier J; Hill DE; Vidal M
    Science; 2008 Oct; 322(5898):104-10. PubMed ID: 18719252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.